Invention Grant
US08501767B2 Imidazopyridines and imidazopyrimidines as HIV-1 reverse transcriptase inhibitors
有权
咪唑并吡啶和咪唑并嘧啶作为HIV-1逆转录酶抑制剂
- Patent Title: Imidazopyridines and imidazopyrimidines as HIV-1 reverse transcriptase inhibitors
- Patent Title (中): 咪唑并吡啶和咪唑并嘧啶作为HIV-1逆转录酶抑制剂
-
Application No.: US13119431Application Date: 2009-09-16
-
Publication No.: US08501767B2Publication Date: 2013-08-06
- Inventor: Moira Leanne Bode , Amanda Louise Rousseau , David Gravestock , Simon Sana Moleele , Christiaan Wynand Van Der Westhuyzen
- Applicant: Moira Leanne Bode , Amanda Louise Rousseau , David Gravestock , Simon Sana Moleele , Christiaan Wynand Van Der Westhuyzen
- Applicant Address: ZA Pretoria
- Assignee: CSIR
- Current Assignee: CSIR
- Current Assignee Address: ZA Pretoria
- Agency: Wilson, Sonsini, Goodrich & Rosati
- Priority: ZA2008/07954 20080916
- International Application: PCT/IB2009/054021 WO 20090916
- International Announcement: WO2010/032195 WO 20100325
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A61K31/44 ; C07D471/02 ; C07D491/02 ; C07D498/02 ; C07D513/02 ; C07D515/02
Abstract:
The invention provides compounds of formula A or B which are useful in the treatment of a subject infected with HIV.
Public/Granted literature
- US20110312957A1 IMIDAZOPYRIDINES AND IMIDAZOPYRIMIDINES AS HIV-I REVERSE TRANSCRIPTASE INHIBITORS Public/Granted day:2011-12-22
Information query
IPC分类:
